Phase 2 Interstitial Lung Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have a confirmed diagnosis of IPF (idiopathic pulmonary fibrosis) and whose lung function test results meet the specific requirements set out in the trial protocol.
• People who agree to use highly effective birth control during the trial and for 6 months after the last dose of the study drug.
• People who are able to understand the study, freely agree in writing to take part, and are willing and able to follow all the trial's required procedures.

Who may not be able to join:

• People who have a known history of drug or other allergies, or whom the trial doctor believes may be allergic to the study drugs.
• People who have another significant lung disease in addition to IPF at the time of screening.
• People for whom lung function testing is not considered safe or appropriate at the time of screening.
• People who have had a respiratory or whole-body infection requiring antibiotic or antiviral treatment in the month before joining the trial.
• People who have had a sudden worsening (acute exacerbation) of their IPF in the 4 months before joining the trial.
• People who have taken any medication known to cause or worsen lung scarring in the 3 months before screening.
• People who have smoked in the 3 months before screening, or who are unwilling to remain smoke-free throughout the trial.
• People who have a significant heart, brain, blood, nerve, mental health, or metabolic condition at screening, or who are planning major surgery during the trial period.
• People whose blood test results show certain abnormalities at screening (confirm specific values with trial site).
• People who show signs of significant kidney impairment or who require dialysis at screening.
• People with an active hepatitis virus infection, or a history of an immune deficiency condition (whether acquired or present from birth).
• People who have had a cancer diagnosis within the 5 years before screening.
• People who have difficulty with blood draws, or who have a history of needle phobia or fear of blood.
• People who have a positive pregnancy test or who are currently breastfeeding at screening.
• People who have taken part in another clinical trial or received another experimental drug within the 3 months before joining this trial.
• People whom the trial doctor considers unsuitable for participation for any other reason.

Important: Always verify eligibility with the trial site directly before applying.